Q2 2025 Earnings Call Transcript July 17, 2025 Abbott Laboratories reports earnings inline with expectations. Reported EPS is ...

Abbott Laboratories (ABT) reports robust earnings growth and margin expansion, driven by medical devices, despite headwinds ...

Live Updates Live Coverage Updates appear automatically as they are published. Still no earnings at 7:05 a.m. ET 7:04 am by ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

Barclays analyst Matt Miksic maintained an Overweight rating and increased the price target from $158 to $159 on April 17, ...

Abbott second-quarter results came in ahead of the consensus forecast, with its Medical Device business growing 13.4%.

"Halfway through the year, we delivered high single-digit organic sales growth, double-digit EPS growth, significantly ...

Abbott Laboratories CEO Robert Ford unpacked his company’s latest quarterly report in a Thursday interview with CNBC’s Jim ...

During the earnings call, CEO Robert Ford noted that the diagnostics business showed solid growth in all regions except China. He mentioned that growth outside China reached about 7% this quarter ...

ABBOTT PARK, Ill., June 26, 2025/ PRNewswire/-- Abbott will announce its second-quarter 2025 financial results on Thursday, July 17, before the market opens. The announcement will be followed by a ...

Q2 2025 Results Conference Call July 17, 2025 9:00 AM ETCompany ParticipantsMichael Comilla - Vice President of ...

The Motley Fool. DATE Thursday, July 17, 2025 at 9 a.m. ET CALL PARTICIPANTS Chairman and Chief Executive Officer — Robert ...